Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SUVEN-LIFE-SCIENCES-LIMIT-6709859/nieuws/Suven-Life-Sciences-kondigt-de-randomisatie-aan-van-de-eerste-patient-in-de-Fase-2-POC-klinische-st-45927058/?utm_source=whatsapp&utm_medium=social&utm_campaign=share